Intercept Pharmaceuticals, Inc. (ICPT) saw a big move last session, as the company’s shares fell by about 6% on the day. The move came on pretty good volume too with far more shares changing hands than in a normal session. This continues the recent downtrend for ICPT, as the stock is now down 34% since Nov 6.
This slump shouldn’t be too much of a surprise to investors, as this biopharmaceutical company has seen 1 negative revision in the past few weeks and its current year loss consensus has widened over the last 30 days. This suggests there may be more trouble down the road. So make sure to keep an eye on this stock going forward to see if this recent slump will continue, as the earnings picture definitely suggests that this might be the case.
ICPT currently has a Zacks Rank #4 (Sell).
Some better-ranked stocks in the Med-Biomed/Generic industry include Affymetrix Inc. (AFFX), AMAG Pharmaceuticals, Inc. (AMAG) and ANI Pharmaceuticals, Inc. (ANIP). All these stocks hold a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Be the first to comment